Enavogliflozin nano eye drops (Daewoong Pharmaceutical)

依那格列净纳米滴眼液 (大熊制药株式会社)

Report date: 2023/10/12 14:21:08

Base Information

Drug NameEnavogliflozin nano eye drops (Daewoong Pharmaceutical)
Drug Alias Name依那格列净改良型纳米滴眼液DWRX2008DWRX-2008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 2 inhibitors
TargetsSodium/glucose cotransporter 2
Therapy Area/IndicationsMacular EdemaDiabetic RetinopathyEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMacular EdemaDiabetic Retinopathy
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A